Product Information

CYCLOSPORINE MODIFIED 100 MG/ML is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0575 per ML under NDC 00172731320. Its NADAC has been published 362 times since Nov 28, 2013.

FDA first approved this application on Mar 25, 2005. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE MODIFIED 100 MG/ML

Cyclosporine
$2.0575per ML

Strength

100 mg/mL

NDC

00172731320

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Generic (ANDA)

FDA Application

ANDA065078

FDA Approved

3/25/2005

TE Code

AB1

On Market Since

3/29/2005

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE MODIFIED 100 MG/ML has been published 362 times since Nov 28, 2013, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0575 per ML
All-time high$4.6427 (Feb 11, 2015)
All-time low$1.7080 (Aug 21, 2024)
52-week high$2.7888
52-week low$2.0240
Median price$2.7793
Average price$2.7531
Largest weekly change+54.8% (Nov 19, 2014)
Weeks tracked362
Tracking sinceNov 28, 2013

Price History

1W

+1.7%

1M

+1.0%

3M

-3.1%

6M

-12.4%

1Y

-26.2%

3Y

-34.6%

5Y

-34.6%

All

-30.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE MODIFIED 100 MG/ML?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 100 MG/ML, manufactured by Teva Pharmaceuticals USA Inc., is $2.0575 per ML (NDC 00172731320), effective Nov 18, 2026.

How has the price of CYCLOSPORINE MODIFIED 100 MG/ML changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 100 MG/ML has declined 30.9%. It has been tracked across 362 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 100 MG/ML?

Since Nov 28, 2013, the NADAC for CYCLOSPORINE MODIFIED 100 MG/ML has ranged from a low of $1.7080 (Aug 21, 2024) to a high of $4.6427 (Feb 11, 2015), with a median of $2.7793 per ML.

Are there cheaper alternatives to CYCLOSPORINE MODIFIED 100 MG/ML?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CYCLOSPORINE MODIFIED 100 MG/ML in a comparable dosage form, but none are currently priced below it.

Who manufactures CYCLOSPORINE MODIFIED 100 MG/ML?

CYCLOSPORINE MODIFIED 100 MG/ML (NDC 00172731320) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.